New mortality data from the federal government suggests that life expectancy probably hit another record high in 2025, as ...

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...

Practice-changing perioperative therapy, chemo-free combo for CSPC, reducing cognitive eff ...

Targeted compound daraxonrasib successfully blocks multiple KRAS variants to double survival limits in clinical trials.

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.